For research purposes only. Not for human consumption.
Description:
IGF-1 LR3 (Long Arg3 Insulin-Like Growth Factor-1) is a synthetic analogue of insulin-like growth factor-1 (IGF-1) developed through targeted amino acid modification to investigate receptor interactions, molecular stability, and peptide signalling within controlled laboratory environments. Structural modifications distinguish IGF-1 LR3 from endogenous IGF-1 and have contributed to its continued interest across biochemical and molecular research disciplines.
Within preclinical research settings, IGF-1 LR3 has been utilised as a reference compound in studies examining receptor-binding characteristics, intracellular signalling pathways, peptide stability, and protein interaction mechanisms. Researchers have also investigated its physicochemical properties, structure-function relationships, and behaviour within controlled experimental models to better understand growth factor biology and cellular communication.
Ongoing scientific research continues to evaluate IGF-1 LR3's molecular characteristics, receptor pharmacology, pharmacokinetic profile, and analytical properties using established laboratory methodologies. Continued investigation aims to further characterise its role as a research compound within peptide science and molecular biology.
